F D'Aiuto, M Parkar, L Nibali, J Suvan, J Lessem, MS … - American Heart Journal, 2006 - Elsevier Compared to control, IPT produced significant reductions in a cluster of inflammatory markers
at 1 (P = .0406) and 2 (P = .0060) months together with an improvement in lipid markers at 2
(P = .0320) and 6 (P = .0432) months after therapy. Intensive periodontal therapy ... Cited by 62 - Related articles - All 5 versions
- ►diabetesjournals.org JS Pankow, DK Kwan, BB Duncan, MI Schmidt, DJ … - Diabetes Care, 2007 - Am Diabetes Assoc RESULTS—Agreement between fasting and postchallenge glucose impairment was poor: 3,048
subjects (44%) had neither impaired fasting glucose (IFG) nor impaired glucose tolerance
(IGT), 1,690 (25%) had isolated IFG, 1,000 (14%) had isolated IGT, and 1,149 (17%) had ... Cited by 24 - Related articles - BL Direct - All 6 versions
- ►asnjournals.org V Menon, T Greene, AA Pereira, X Wang, GJ … - Journal of the American …, 2005 - Am Soc Nephrol In the general population, hyperglycemia in the absence of diabetes may be associated with
increased risk for mortality. Hyperglycemia is prevalent in chronic kidney disease; however, the
relationship between glycosylated hemoglobin (HbA 1c ) as a marker of chronic ... Cited by 25 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org FM Chung, JCR Tsai, DM Chang, SJ Shin, YJ Lee - Diabetes care, 2005 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—For this study, 1,480 subjects with type 2 diabetes who
were enrolled in a disease management program were stratified according to urinary microalbumin
and serum creatinine measurements. The total and differential leukocyte profiles of ... Cited by 14 - Related articles - BL Direct - All 5 versions
JPH van Wijk, MC Cabezas, B Coll, J Joven, TJ … - Atherosclerosis, 2006 - Elsevier A randomized, 8-week, cross-over, placebo-controlled, double-blind clinical trial was performed
in 19 patients with type 2 diabetes. Standardized 6-h oral fat-loading tests were performed after
each treatment period. During placebo treatment, blood leukocytes increased to a ... Cited by 13 - Related articles - All 19 versions
WS Shim, HJ Kim, ES Kang, CW Ahn, SK Lim, HC … - Diabetes research and …, 2006 - Elsevier The number of components of MS and prevalence of MS were increased from 1st quartile to
4th quartile of WBC count. Total WBC, neutrophil, lymphocyte, monocyte and eosinophil counts
were increased with the increase of number of components of MS except basophil count. ... Cited by 12 - Related articles - All 9 versions
A Veronelli, M Laneri, R Ranieri, D Koprivec, D … - Diabetes care, 2004 - Am Diabetes Assoc White blood cell (WBC) count is elevated in obesity (1) and is a risk factor for atherosclerosis
(2). An elevated WBC count is present in impaired glucose tolerance (IGT) (3), and WBC count
is associated with macro- and microangiopathic complications in type 2 diabetes (4). In ... Cited by 10 - Related articles - BL Direct - All 5 versions
CRT Jack, SH Sheu, HC Chiu, FM Chung, DM … - Diabetes/Metabolism … - interscience.wiley.com There is increasing evidence that leukocytes play a central role in obesity, glucose
intolerance, type 2 diabetes mellitus (T2DM), and cardiovascular diseases, but the role of differential
leukocytes in metabolic syndrome (MetS) and atherosclerosis is largely unknown. The ... Cited by 8 - Related articles - BL Direct - All 3 versions
